Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × reolysin × Clear all

NCT01619813 2023-08-04

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms